Verve Therapeutics Ownership 2024 | Who Owns Verve Therapeutics Now?
Institutional Ownership
91.55%
Insider Ownership
7.75%
Retail Ownership
0.70%
Institutional Holders
164.00
Verve Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALPHABET INC. | 14.85% | 3.05% | 12,349,086 | - | - | 60,263,539 | Jun 30, 2024 |
| BLACKROCK INC. | 7.96% | 0.00% | 6,620,004 | 1,246,827 | 23.20% | 32,305,619 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.33% | 0.00% | 5,263,509 | -1,067,803 | -16.87% | 25,685,925 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 5.45% | 0.01% | 4,528,712 | -47,712 | -1.04% | 22,101,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 4.66% | 0.01% | 3,870,840 | 3,256,410 | 529.99% | 18,889,699 | Jun 30, 2024 |
| STATE STREET CORP | 4.03% | 0.00% | 3,349,408 | -1,748,000 | -34.29% | 16,345,111,000 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 3.68% | 1.14% | 3,059,094 | - | - | 14,928,379 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 3.53% | 0.13% | 2,936,063 | -3,104,413 | -51.39% | 14,327,987 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 2.89% | 0.68% | 2,400,000 | 400,000 | 20.00% | 11,712,000 | Jun 30, 2024 |
| ARCH VENTURE MANAGEMENT, LLC | 2.42% | 3.69% | 2,008,809 | - | - | 9,802,988 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 2.03% | 0.11% | 1,691,530 | - | - | 8,254,666 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 2.03% | 0.00% | 1,691,352 | 198,302 | 13.28% | 8,253,797 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.88% | 0.00% | 1,559,772 | 110,346 | 7.61% | 7,612,835 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 1.76% | 0.43% | 1,463,406 | -141,109 | -8.79% | 7,141,421 | Jun 30, 2024 |
| FMR LLC | 1.70% | 0.00% | 1,415,120 | -1,962,354 | -58.10% | 6,905,785 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.55% | 0.00% | 1,288,249 | 457,379 | 55.05% | 6,286,655 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 1.50% | 0.19% | 1,250,000 | - | - | 6,100,000 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 1.39% | 0.01% | 1,151,550 | -2,405,027 | -67.62% | 5,619,564,000 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 1.34% | 0.00% | 1,115,466 | -1,476,732 | -56.97% | 5,443,474 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 1.34% | 0.06% | 1,115,466 | -1,476,732 | -56.97% | 5,432,319 | Jun 30, 2024 |
Verve Therapeutics's largest institutional shareholder is ALPHABET INC., holding 14.85% of the company's total share outstanding, currently valued at $60.26M. The top 10 institutional shareholders own together 55.80% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARCH VENTURE MANAGEMENT, LLC | 2.42% | 3.69% | 2,008,809 | - | - | 9,802,988 | Jun 30, 2024 |
| ALPHABET INC. | 14.85% | 3.05% | 12,349,086 | - | - | 60,263,539 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 3.68% | 1.14% | 3,059,094 | - | - | 14,928,379 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 2.89% | 0.68% | 2,400,000 | 400,000 | 20.00% | 11,712,000 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.77% | 0.48% | 638,163 | - | - | 3,114,235 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 1.76% | 0.43% | 1,463,406 | -141,109 | -8.79% | 7,141,421 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 0.69% | 0.33% | 575,817 | - | - | 2,809,987 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 1.50% | 0.19% | 1,250,000 | - | - | 6,100,000 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.60% | 0.18% | 500,000 | 500,000 | 100.00% | 2,440,000 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.40% | 0.15% | 333,864 | 143,256 | 75.16% | 1,629,256 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 3.53% | 0.13% | 2,936,063 | -3,104,413 | -51.39% | 14,327,987 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 2.03% | 0.11% | 1,691,530 | - | - | 8,254,666 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.42% | 0.10% | 350,000 | - | - | 1,708,000 | Jun 30, 2024 |
| 0.02% | 0.09% | 14,599 | 14,599 | 100.00% | 66,279 | Jun 30, 2024 | |
| BVF INC/IL | 0.78% | 0.09% | 650,000 | - | - | 3,172,000 | Jun 30, 2024 |
| GREEN ALPHA ADVISORS, LLC | 0.02% | 0.08% | 19,433 | -5,507 | -22.08% | 94,833 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.24% | 0.07% | 203,677 | 203,677 | 100.00% | 994,000 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 1.34% | 0.06% | 1,115,466 | -1,476,732 | -56.97% | 5,432,319 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.03% | 0.05% | 22,706 | 22,706 | 100.00% | 110,805 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.06% | 0.04% | 47,361 | 35,562 | 301.40% | 231,122 | Jun 30, 2024 |
The largest Verve Therapeutics shareholder by % of total assets is ARCH VENTURE MANAGEMENT, LLC. The company owns 2.01M shares of Verve Therapeutics (VERV), representing 3.69% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 4.66% | 0.01% | 3,870,840 | 3,256,410 | 529.99% | 18,889,699 | Jun 30, 2024 |
| BLACKROCK INC. | 7.96% | 0.00% | 6,620,004 | 1,246,827 | 23.20% | 32,305,619 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.09% | 0.02% | 905,815 | 905,815 | 100.00% | 4,420,377 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.60% | 0.18% | 500,000 | 500,000 | 100.00% | 2,440,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.55% | 0.00% | 1,288,249 | 457,379 | 55.05% | 6,286,655 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 2.89% | 0.68% | 2,400,000 | 400,000 | 20.00% | 11,712,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.73% | 0.01% | 607,473 | 361,891 | 147.36% | 2,964,468 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.63% | 0.04% | 523,393 | 360,630 | 221.57% | 2,554,158 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.48% | 0.01% | 395,699 | 281,173 | 245.51% | 1,931,011 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 474,500 | 275,173 | 138.05% | 2,315,560 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.29% | 0.00% | 242,468 | 242,468 | 100.00% | 1,183,244 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.24% | 0.07% | 203,677 | 203,677 | 100.00% | 994,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 2.03% | 0.00% | 1,691,352 | 198,302 | 13.28% | 8,253,797 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.17% | 0.00% | 144,027 | 144,027 | 100.00% | 702,177 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.40% | 0.15% | 333,864 | 143,256 | 75.16% | 1,629,256 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.17% | 0.02% | 137,496 | 137,496 | 100.00% | 671,000 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.16% | 0.01% | 132,998 | 118,628 | 825.53% | 649,030 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.45% | 0.00% | 371,300 | 118,266 | 46.74% | 1,811,943 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.17% | 0.02% | 142,514 | 113,872 | 397.57% | 695,468 | Jun 30, 2024 |
| MAN GROUP PLC | 0.15% | 0.00% | 125,591 | 110,456 | 729.81% | 612,884 | Jun 30, 2024 |
As of Jun 30 2024, Verve Therapeutics's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 3.26M stocks of VERV, valued at $18.89M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 3.53% | 0.13% | 2,936,063 | -3,104,413 | -51.39% | 14,327,987 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 1.39% | 0.01% | 1,151,550 | -2,405,027 | -67.62% | 5,619,564,000 | Jun 30, 2024 |
| FMR LLC | 1.70% | 0.00% | 1,415,120 | -1,962,354 | -58.10% | 6,905,785 | Jun 30, 2024 |
| STATE STREET CORP | 4.03% | 0.00% | 3,349,408 | -1,748,000 | -34.29% | 16,345,111,000 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 1.34% | 0.06% | 1,115,466 | -1,476,732 | -56.97% | 5,432,319 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 1.34% | 0.00% | 1,115,466 | -1,476,732 | -56.97% | 5,443,474 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.33% | 0.00% | 5,263,509 | -1,067,803 | -16.87% | 25,685,925 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -521,112 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -310,205 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -310,000 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.75% | 0.00% | 623,730 | -261,836 | -29.57% | 3,043,802 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.27% | 0.00% | 226,348 | -247,235 | -52.21% | 1,104,578 | Jun 30, 2024 |
| UBS GROUP AG | 0.13% | 0.00% | 106,702 | -185,282 | -63.46% | 520,705 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 2,507 | -169,288 | -98.54% | 11,933 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 1.76% | 0.43% | 1,463,406 | -141,109 | -8.79% | 7,141,421 | Jun 30, 2024 |
| VESTMARK ADVISORY SOLUTIONS, INC. | - | - | - | -106,093 | -100.00% | - | Jun 30, 2024 |
| CLARIVEST ASSET MANAGEMENT LLC | 0.00% | 0.00% | 584 | -77,043 | -99.25% | 2,849 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.97% | 0.00% | 810,497 | -64,722 | -7.39% | 3,955,226 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.52% | 0.00% | 436,388 | -55,003 | -11.19% | 2,128,849 | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | - | - | - | -48,467 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Verve Therapeutics's biggest institutional seller is ARK INVESTMENT MANAGEMENT LLC. The company sold -3.10M shares of VERV, valued at $14.33M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.09% | 0.02% | 905,815 | 905,815 | 100.00% | 4,420,377 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.60% | 0.18% | 500,000 | 500,000 | 100.00% | 2,440,000 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.29% | 0.00% | 242,468 | 242,468 | 100.00% | 1,183,244 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.24% | 0.07% | 203,677 | 203,677 | 100.00% | 994,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.17% | 0.00% | 144,027 | 144,027 | 100.00% | 702,177 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.13% | 0.01% | 103,991 | 103,991 | 100.00% | 507,476 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.12% | 0.00% | 100,000 | 100,000 | 100.00% | 488,000 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.12% | 0.00% | 95,571 | 95,571 | 100.00% | 466,387 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.11% | 0.00% | 89,248 | 89,248 | 100.00% | 435,530 | Jun 30, 2024 |
| NORGES BANK | 0.09% | 0.00% | 78,186 | 78,186 | 100.00% | 381,548 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.07% | 0.00% | 61,815 | 61,815 | 100.00% | 301,657 | Jun 30, 2024 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 0.06% | 0.00% | 46,100 | 46,100 | 100.00% | 224,968 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.05% | 0.04% | 44,000 | 44,000 | 100.00% | 214,720 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 38,220 | 38,220 | 100.00% | 186,514 | Jun 30, 2024 |
| CIM INVESTMENT MANAGEMENT INC | 0.03% | 0.04% | 27,508 | 27,508 | 100.00% | 134,239 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.03% | 0.01% | 23,097 | 23,097 | 100.00% | 113,000 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.03% | 0.05% | 22,706 | 22,706 | 100.00% | 110,805 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.03% | 0.02% | 21,471 | 21,471 | 100.00% | 104,778 | Jun 30, 2024 |
| QUANTINNO CAPITAL MANAGEMENT LP | 0.02% | 0.00% | 19,414 | 19,414 | 100.00% | 94,740 | Jun 30, 2024 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 0.02% | 0.00% | 18,000 | 18,000 | 100.00% | 87,840 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.02% | - | 17,217 | 17,217 | 100.00% | 80,247 | Jun 30, 2024 |
| 0.02% | 0.09% | 14,599 | 14,599 | 100.00% | 66,279 | Jun 30, 2024 | |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | 0.00% | 4,400 | 4,400 | 100.00% | 21,472 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.00% | 0.00% | 3,558 | 3,558 | 100.00% | 17,363 | Jun 30, 2024 |
| AMUNDI | 0.00% | - | 3,208 | 3,208 | 100.00% | 16,489 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 2,000 | 2,000 | 100.00% | 9,760 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.00% | - | 1,700 | 1,700 | 100.00% | 8,296 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 826 | 826 | 100.00% | 4,000 | Jun 30, 2024 |
| LARSON FINANCIAL GROUP LLC | 0.00% | 0.00% | 260 | 260 | 100.00% | 1,269 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | 0.00% | - | 170 | 170 | 100.00% | 1,172 | Jun 30, 2024 |
Verve Therapeutics's largest new institutional shareholder by number of shares is JACOBS LEVY EQUITY MANAGEMENT, INC, purchased 905.82K shares, valued at $4.42M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | - | - | - | -521,112 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -310,205 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -310,000 | -100.00% | - | Jun 30, 2024 |
| VESTMARK ADVISORY SOLUTIONS, INC. | - | - | - | -106,093 | -100.00% | - | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | - | - | - | -48,467 | -100.00% | - | Jun 30, 2024 |
| ALPHA DNA INVESTMENT MANAGEMENT LLC | - | - | - | -37,640 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -33,115 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -32,468 | -100.00% | - | Jun 30, 2024 |
| BELLEVUE GROUP AG | - | - | - | -29,200 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -26,126 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -20,394 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| QUEST PARTNERS LLC | - | - | - | -18,044 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -17,011 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -16,669 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -15,649 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -15,283 | -100.00% | - | Jun 30, 2024 |
| SVB WEALTH LLC | - | - | - | -12,170 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -11,504 | -100.00% | - | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | - | - | - | -6,000 | -100.00% | - | Jun 30, 2024 |
| CI INVESTMENTS INC. | - | - | - | -5,433 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -4,040 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,526 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -2,073 | -100.00% | - | Jun 30, 2024 |
| KBC GROUP NV | - | - | - | -1,750 | -100.00% | - | Jun 30, 2024 |
| MACROVIEW INVESTMENT MANAGEMENT LLC | - | - | - | -587 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -544 | -100.00% | - | Jun 30, 2024 |
| NBC SECURITIES, INC. | - | - | - | -150 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -92 | -100.00% | - | Jun 30, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | - | - | -22 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
Verve Therapeutics's largest sold out institutional shareholder by shares sold is WOODLINE PARTNERS LP, sold -0.52M shares, valued at -, as of undefined.
Verve Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Manager Directed Portfolios | 0.89% | 145,270 | - | - | Jan 31, 2024 |
| Ark ETF Trust | 0.75% | 5,999,417 | 354,132 | 6.27% | Jan 31, 2024 |
| Tema ETF Trust | 0.72% | 32,093 | 21,470 | 202.11% | Feb 29, 2024 |
| Kelly Strategic ETF Trust | 0.37% | 9,968 | - | - | Feb 29, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.26% | 952,130 | 169,700 | 21.69% | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.18% | 3,603,293 | 996,369 | 38.22% | Jan 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.16% | 1,285,711 | 490,280 | 61.64% | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.15% | 315,668 | - | - | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.07% | 330,532 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 32,020 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.04% | 374,194 | -171,700 | -31.45% | Jan 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.04% | 457,905 | 85,300 | 22.89% | Mar 31, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.03% | 66,900 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.03% | 290,530 | - | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 614,059 | -23,316 | -3.66% | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 115,469 | 21,621 | 23.04% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,534 | 1,697 | 21.65% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 5,685,024 | 37,175 | 0.66% | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.01% | 54,200 | -11,295 | -17.25% | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.01% | 2,169 | - | - | Mar 28, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 1,018,589 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 31,848 | 1,698 | 5.63% | Feb 29, 2024 |
| FORUM FUNDS II | 0.01% | 8,186 | 86 | 1.06% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.01% | 18,500 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 49,655 | -3,977 | -7.42% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,017 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 44,919 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 12,177 | 4,379 | 56.16% | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 5,731 | -51 | -0.88% | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 16,098 | 8,135 | 102.16% | Mar 31, 2024 |
| Bernstein Fund Inc | 0.00% | 33,170 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 29,100 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 139,554 | 3,829 | 2.82% | Jan 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 45,016 | 9,835 | 27.96% | Feb 29, 2024 |
| Investment Managers Series Trust II | 0.00% | 34,484 | 15,855 | 85.11% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 6,570 | 1,530 | 30.36% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 496,876 | 67,836 | 15.81% | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 144,393 | -64,200 | -30.78% | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 337,958 | 78,036 | 30.02% | Jan 31, 2024 |
| ProFunds | 0.00% | 22,422 | 4,889 | 27.88% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,275 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 39,284 | -2,851 | -6.77% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 105,562 | - | - | Jan 31, 2024 |
| FIDELITY CONTRAFUND | 0.00% | 80,849 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 25,497 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 39,900 | - | - | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 186,881 | 21,461 | 12.97% | Feb 29, 2024 |
| JPMORGAN TRUST II | 0.00% | 747,436 | - | - | Feb 29, 2024 |
| Ultimus Managers Trust | 0.00% | 8,343 | - | - | Feb 29, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 213,654 | - | - | Dec 31, 2023 |
| Principal Exchange-Traded Funds | 0.00% | 8,128 | -669 | -7.60% | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 70,453 | 12,000 | 20.53% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 20,741 | 42 | 0.20% | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 1,025 | 187 | 22.32% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,988 | 535 | 21.81% | Mar 31, 2024 |
| Global X Funds | 0.00% | 22,824 | -54,121 | -70.34% | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 10,781 | 1,138 | 11.80% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 204,829 | 204,829 | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 3,057 | - | - | Aug 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 50,467 | 23,493 | 87.09% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 9,110 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 124,570 | -12,169 | -8.90% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 243,435 | 8,804 | 3.75% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 7,619 | - | - | Feb 29, 2024 |
| BLACKROCK LARGE CAP SERIES FUNDS, INC. | 0.00% | 17,862 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 25,200 | 5,500 | 27.92% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 51,959 | -3,618 | -6.51% | Mar 28, 2024 |
| Managed Portfolio Series | 0.00% | 7,310 | 7,310 | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 14,163 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 41,110 | 19,746 | 92.43% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 5,598 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,704 | 178 | 7.05% | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 19,469 | 7,649 | 64.71% | Feb 29, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 220,780 | 17,120 | 8.41% | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 537,460 | 437,917 | 439.93% | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 2,859,551 | 439,214 | 18.15% | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 13,868 | 10,724 | 341.09% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 175,375 | 43,577 | 33.06% | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 568 | - | - | Mar 28, 2024 |
| JPMorgan Trust I | 0.00% | 140,182 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 229,689 | 30,611 | 15.38% | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 119,623 | 96,414 | 415.42% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 463 | - | - | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES I | 0.00% | 19,900 | -49,500 | -71.33% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 3,660,146 | 875,790 | 31.45% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,300 | 700 | 43.75% | Mar 28, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 26,501 | 914 | 3.57% | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 7,420 | -375 | -4.81% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 229 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 13,348 | 2,731 | 25.72% | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,455 | - | - | Mar 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 8,116 | 8,116 | - | Jan 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 4,499 | 4,499 | - | Mar 31, 2024 |
| Pacer Funds Trust | 0.00% | 1,667 | -136 | -7.54% | Jan 31, 2024 |
| FIDELITY HASTINGS STREET TRUST | 0.00% | 243,400 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 194 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 32,037 | 32,037 | - | Jan 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 108,322 | 98,918 | 1051.87% | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 6,942 | 2,251 | 47.99% | Jan 31, 2024 |
| AMERICAN BEACON FUNDS | 0.00% | 110,691 | - | - | Feb 29, 2024 |
Verve Therapeutics's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 145.27K shares, compromising 0.89% of its total assets.
Verve Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 164 | -0.61% |
| 31 Mar, 24 | 165 | 3.13% |
| 31 Dec, 23 | 160 | 13.48% |
| 30 Sep, 23 | 141 | 12.80% |
| 30 Jun, 23 | 125 | -0.79% |
| 31 Mar, 23 | 126 | 1.61% |
| 31 Dec, 22 | 124 | -6.77% |
| 30 Sep, 22 | 133 | 34.34% |
| 30 Jun, 22 | 99 | 5.32% |
| 31 Mar, 22 | 94 | - |
| 31 Dec, 21 | 94 | 28.77% |
| 30 Sep, 21 | 73 | 5.80% |
| 30 Jun, 21 | 69 | - |
As of 30 Jun 24, 164 institutions are holding Verve Therapeutics's shares, representing a decrease of -0.61% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 76,109,587 | -6.75% |
| 31 Mar, 24 | 81,620,773 | 9.36% |
| 31 Dec, 23 | 74,631,879 | 17.01% |
| 30 Sep, 23 | 63,785,080 | 3.08% |
| 30 Jun, 23 | 61,879,660 | -2.20% |
| 31 Mar, 23 | 63,268,554 | 1.03% |
| 31 Dec, 22 | 62,621,868 | 3.19% |
| 30 Sep, 22 | 60,686,828 | 33.20% |
| 30 Jun, 22 | 45,559,224 | -2.31% |
| 31 Mar, 22 | 46,636,132 | 3.27% |
| 31 Dec, 21 | 45,160,419 | 16.64% |
| 30 Sep, 21 | 38,717,779 | 2.76% |
| 30 Jun, 21 | 37,677,848 | - |
Verve Therapeutics (VERV) has 76.11M shares outstanding as of 30 Jun 24, down -6.75% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 91.55% | 0.95% |
| 31 Mar, 24 | 98.18% | 0.86% |
| 31 Dec, 23 | 107.12% | 1.05% |
| 30 Sep, 23 | 100.91% | 1.01% |
| 30 Jun, 23 | 99.88% | 0.95% |
| 31 Mar, 23 | 102.40% | 0.99% |
| 31 Dec, 22 | 101.88% | 0.91% |
| 30 Sep, 22 | 106.08% | 1.21% |
| 30 Jun, 22 | 93.60% | 1.02% |
| 31 Mar, 22 | 96.02% | 1.09% |
| 31 Dec, 21 | 94.03% | 1.44% |
| 30 Sep, 21 | 80.67% | 1.31% |
| 30 Jun, 21 | 78.58% | - |
As of 30 Jun 24, Verve Therapeutics is held by 91.55% institutional shareholders, representing a 0.95% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 96 | -4.95% |
| 31 Mar, 24 | 101 | -8.18% |
| 31 Dec, 23 | 110 | 26.44% |
| 30 Sep, 23 | 87 | 38.10% |
| 30 Jun, 23 | 63 | - |
| 31 Mar, 23 | 63 | -13.70% |
| 31 Dec, 22 | 73 | -27.00% |
| 30 Sep, 22 | 100 | 78.57% |
| 30 Jun, 22 | 56 | -3.45% |
| 31 Mar, 22 | 58 | -3.33% |
| 31 Dec, 21 | 60 | 20.00% |
| 30 Sep, 21 | 50 | -27.54% |
| 30 Jun, 21 | 69 | - |
96 institutional shareholders have increased their position in VERV stock as of 30 Jun 24 compared to 101 in the previous quarter (a -4.95% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 45 | 12.50% |
| 31 Mar, 24 | 40 | 60.00% |
| 31 Dec, 23 | 25 | 8.70% |
| 30 Sep, 23 | 23 | -39.47% |
| 30 Jun, 23 | 38 | 11.76% |
| 31 Mar, 23 | 34 | 17.24% |
| 31 Dec, 22 | 29 | 93.33% |
| 30 Sep, 22 | 15 | -25.00% |
| 30 Jun, 22 | 20 | -9.09% |
| 31 Mar, 22 | 22 | 22.22% |
| 31 Dec, 21 | 18 | 38.46% |
| 30 Sep, 21 | 13 | - |
| 30 Jun, 21 | - | - |
45 institutional shareholders have reduced their position in VERV stock as of 30 Jun 24 compared to 40 in the previous quarter (a 12.50% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 164 | -0.61% | 76,109,587 | -6.75% | 91.55% | 0.95% | 96 | -4.95% | 45 | 12.50% |
| 31 Mar, 24 | 165 | 3.13% | 81,620,773 | 9.36% | 98.18% | 0.86% | 101 | -8.18% | 40 | 60.00% |
| 31 Dec, 23 | 160 | 13.48% | 74,631,879 | 17.01% | 107.12% | 1.05% | 110 | 26.44% | 25 | 8.70% |
| 30 Sep, 23 | 141 | 12.80% | 63,785,080 | 3.08% | 100.91% | 1.01% | 87 | 38.10% | 23 | -39.47% |
| 30 Jun, 23 | 125 | -0.79% | 61,879,660 | -2.20% | 99.88% | 0.95% | 63 | - | 38 | 11.76% |
| 31 Mar, 23 | 126 | 1.61% | 63,268,554 | 1.03% | 102.40% | 0.99% | 63 | -13.70% | 34 | 17.24% |
| 31 Dec, 22 | 124 | -6.77% | 62,621,868 | 3.19% | 101.88% | 0.91% | 73 | -27.00% | 29 | 93.33% |
| 30 Sep, 22 | 133 | 34.34% | 60,686,828 | 33.20% | 106.08% | 1.21% | 100 | 78.57% | 15 | -25.00% |
| 30 Jun, 22 | 99 | 5.32% | 45,559,224 | -2.31% | 93.60% | 1.02% | 56 | -3.45% | 20 | -9.09% |
| 31 Mar, 22 | 94 | - | 46,636,132 | 3.27% | 96.02% | 1.09% | 58 | -3.33% | 22 | 22.22% |
| 31 Dec, 21 | 94 | 28.77% | 45,160,419 | 16.64% | 94.03% | 1.44% | 60 | 20.00% | 18 | 38.46% |
| 30 Sep, 21 | 73 | 5.80% | 38,717,779 | 2.76% | 80.67% | 1.31% | 50 | -27.54% | 13 | - |
| 30 Jun, 21 | 69 | - | 37,677,848 | - | 78.58% | - | 69 | - | - | - |
Verve Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Verve Therapeutics's stock was made by Kathiresan Sekar on Jul 02 2024, selling 30,000 shares at $2.87 per share (valued at $86.10K).
Verve Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 11 | 14 | 78.57% |
| Q1 2024 | 12 | - | - |
| Q4 2023 | 2 | 2 | 100.00% |
| Q3 2023 | 1 | - | - |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 5 | 5 | 100.00% |
| Q4 2022 | 4 | 73 | 5.48% |
| Q3 2022 | 5 | 10 | 50.00% |
| Q2 2022 | 11 | 3 | 366.67% |
| Q1 2022 | 7 | 10 | 70.00% |
| Q4 2021 | 9 | 17 | 52.94% |
| Q2 2021 | 39 | 55 | 70.91% |
11 total buy trades, and 14 total sell trades (buy/sell ratio of 0.79%) were made by Verve Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 1 | 1 | 100.00% |
| Q1 2024 | - | - | - |
| Q4 2023 | 1 | 1 | 100.00% |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 58 | - |
| Q3 2022 | - | 7 | - |
| Q2 2022 | 1 | 3 | 33.33% |
| Q1 2022 | 1 | 9 | 11.11% |
| Q4 2021 | 2 | 12 | 16.67% |
| Q2 2021 | 9 | - | - |
As of Q2 2024, Insider owners conducted 1 open market buy trades and 1 open market sell trades of Verve Therapeutics's stocks.
Verve Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| SANA | Sana Biotechnology, Inc. |
| ADPT | Adaptive Biotechnologies Corporation |
| CRSP | CRISPR Therapeutics AG |
| BPMC | Blueprint Medicines Corporation |
| IPSC | Century Therapeutics, Inc. |
| NTLA | Intellia Therapeutics, Inc. |
| EDIT | Editas Medicine, Inc. |
| PRME | Prime Medicine, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| CRBU | Caribou Biosciences, Inc. |
| BEAM | Beam Therapeutics Inc. |
| LIFE | aTyr Pharma, Inc. |
VERV Ownership FAQ
Who Owns Verve Therapeutics?
Verve Therapeutics is owned by institutional shareholders (91.55%), insiders (7.75%), and public (0.70%). The largest institutional shareholder of Verve Therapeutics is ALPHABET INC. (14.85% of total shares) and the top mutual fund owner is Manager Directed Portfolios (0.89% of total shares).
Who are the major institutional shareholders of Verve Therapeutics?
Verve Therapeutics's major institutional shareholders are ALPHABET INC., BLACKROCK INC., VANGUARD GROUP INC, T. ROWE PRICE INVESTMENT MANAGEMENT, INC., and MILLENNIUM MANAGEMENT LLC. The top five shareholders own together 39.25% of the company's share outstanding.
How many Verve Therapeutics shareholders are there?
As of Jun 2024, there are 164 institutional shareholders of Verve Therapeutics.
What percentage of Verve Therapeutics is owned by ALPHABET INC?
ALPHABET INC owns 12.35M shares of Verve Therapeutics, representing 14.85% of the company's total shares outstanding, valued at $60.26M (as of Jun 2024).
What percentage of Verve Therapeutics is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 6.62M shares of Verve Therapeutics (VERV), compromising 7.96% of the company, valued at $32.31M.
What percentage of Verve Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Verve Therapeutics. The company owns 5.26M of the company's shares outstanding (worth $25.69M).